Cancer Biotherapy & Radiopharmaceuticals, 1557-8852
Tidskrift
- 2020
Preclinical Single Photon Emission Computed Tomography of Alpha Particle-Emitting Radium-223
Diane S. Abou, Andrew Rittenbach, Ryan E. Tomlinson, Paige A. Finley, Benjamin Tsui, Brian W. Simons, Abhinav K. Jha, David Ulmert, Ryan C. Riddle & Daniel L.J. Thorek, 2020, I: Cancer Biotherapy and Radiopharmaceuticals. 35, 7, s. 520-529 10 s.Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
- 2018
-
Simultaneous Preclinical Positron Emission Tomography-Magnetic Resonance Imaging Study of Lymphatic Drainage of Chelator-Free Cu-Labeled Nanoparticles
Renata Madru, Michael Budassi, Helene Benveniste, Hedok Lee, S David Smith, David J Schlyer, Paul Vaska, Linda Knutsson & Sven-Erik Strand, 2018 aug, I: Cancer Biotherapy & Radiopharmaceuticals. 33, 6, s. 213-220 8 s.Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
- 2015
Cancer Cell Radiobiological Studies Using In-House-Developed α-Particle Irradiator.
Jenny Nilsson, Monika Bauden, Jonas Nilsson, Sven-Erik Strand & Jörgen Elgqvist, 2015, I: Cancer Biotherapy & Radiopharmaceuticals. 30, 9, s. 386-394Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
- 2014
-
Change in Cell Death Markers During (177)Lu-mAb Radioimmunotherapy-Induced Rejection of Syngeneic Rat Colon Carcinoma.
Erika Elgström, Otto Ljungberg, Sophie Eriksson, Anders Örbom, Sven-Erik Strand, Tomas G Ohlsson, Rune Nilsson & Jan Tennvall, 2014, I: Cancer Biotherapy & Radiopharmaceuticals. 29, 4, s. 143-152Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
-
Sequential Radioimmunotherapy with (177)Lu- and (211)At-Labeled Monoclonal Antibody BR96 in a Syngeneic Rat Colon Carcinoma Model.
Sophie Eriksson, Erika Elgström, Tom Bäck, Tomas G Ohlsson, Holger Jensen, Rune Nilsson, Sture Lindegren & Jan Tennvall, 2014, I: Cancer Biotherapy & Radiopharmaceuticals. 29, 6, s. 238-246Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
- 2012
Patient-Specific Whole-Body Attenuation Correction Maps from a CT System for Conjugate-View-Based Activity Quantification: Method Development and Evaluation.
Katarina Sjögreen Gleisner & Michael Ljungberg, 2012, I: Cancer Biotherapy & Radiopharmaceuticals. 27, 10, s. 652-664Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
-
Repeated Radioimmunotherapy with (177)Lu-DOTA-BR96 in a Syngeneic Rat Colon Carcinoma Model.
Sophie Eriksson, Tomas G Ohlsson, Rune Nilsson & Jan Tennvall, 2012, I: Cancer Biotherapy & Radiopharmaceuticals. 27, 2, s. 134-140Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
Targeting Free Prostate-Specific Antigen for In Vivo Imaging of Prostate Cancer Using a Monoclonal Antibody Specific for Unique Epitopes Accessible on Free Prostate-Specific Antigen Alone.
Susan Evans Axelsson, David Ulmert, Anders Örbom, Pernilla Peterson, Olle Nilsson, Johan Wennerberg, Joanna Strand, Karin Wingårdh, Tomas Olsson, Zandra Hagman, Vladimir Tolmachev, Anders Bjartell, Hans Lilja & Sven-Erik Strand, 2012, I: Cancer Biotherapy & Radiopharmaceuticals. 27, 4, s. 243-251Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
Treatment with Unlabeled mAb BR96 After Radioimmunotherapy with (177)Lu-DOTA-BR96 in a Syngeneic Rat Colon Carcinoma Model.
Sophie Eriksson, Tomas G Ohlsson, Rune Nilsson & Jan Tennvall, 2012, I: Cancer Biotherapy & Radiopharmaceuticals. 27, 3, s. 175-182Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
- 2009
-
Development and evaluation of a pharmacokinetic model for prediction of radioimmunotherapy based on pretherapy data.
Mattias Nickel, Sven-Erik Strand, Ola Lindén, Karin Wingårdh, Jan Tennvall & Katarina Sjögreen Gleisner, 2009, I: Cancer Biotherapy & Radiopharmaceuticals. 24, 1, s. 111-121Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
-
Early changes in 2-deoxy-2-[18F]fluoro-D-glucose metabolism in squamous-cell carcinoma during chemotherapy in vivo and in vitro.
Maria Bjurberg, Eva Henriksson, Eva Brun, Lars Ekblad, Tomas G Ohlsson, Arne Brun & Elisabeth Kjellén, 2009, I: Cancer Biotherapy & Radiopharmaceuticals. 24, 3, s. 327-332Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
-
Glomerular Filtration Rate After Alpha-Radioimmunotherapy with At-211-MX35-F(ab ')(2): A Long-Term Study of Renal Function in Nude Mice
Tom Back, Boerje Haraldsson, Ragnar Hultborn, Holger Jensen, Martin Johansson, Sture Lindegren & Lars Jacobsson, 2009, I: Cancer Biotherapy & Radiopharmaceuticals. 24, 6, s. 649-658Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
- 2008
-
Evaluation of toxicity-reducing potential of ECAT in combination with drug-conjugated mAb BR96
Linda Mårtensson, Rune Nilsson, Hans Olov Sjögren & Jan Tennvall, 2008, I: Cancer Biotherapy and Radiopharmaceuticals. 23, 4, s. 520-520Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract
-
Extracorporeal adsorption therapy: a method to improve targeted radiation delivered by radiometal-labeled monoclonal antibodies.
ER Nemecek, DJ Green, DR Fischer, JM Pagel, Y Lin, AK Gopal, LD Durack, JG Rajendran, DS Wilbur, Rune Nilsson, Bengt Sandberg & OW Press, 2008, I: Cancer Biotherapy & Radiopharmaceuticals. 23, 2, s. 181-191Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
-
High dose radioimmunotherapy combined with extracorporeal depletion in syngeneic rat tumor model. Evaluation of toxicity, therapeutic effect, and tumor model
Linda Mårtensson, Rune Nilsson, Tomas G Ohlsson, Hans Olov Sjögren, Sven-Erik Strand & Jan Tennvall, 2008, I: Cancer Biotherapy and Radiopharmaceuticals. 23, 4, s. 517-517Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract
-
Peptide receptor radionuclide therapy (PRRT) using Lu-177-Dotatate: Early clinical and dosimetric results
Michael Garkavij, Katarina Sjögreen Gleisner, Mattias Nickel, Tomas G Ohlsson, Karin Wingårdh & Jan Tennvall, 2008, I: Cancer Biotherapy and Radiopharmaceuticals. 23, 4, s. 524-525Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract
-
Quantitative serial imaging of an I-124 anti-CEA monoclonal antibody in tumor-bearing mice
James R. Bading, Magnus Horling, Lawrence E. Williams, David Colcher, Andrew Raubitschek & Sven-Erik Strand, 2008, I: Cancer Biotherapy & Radiopharmaceuticals. 23, 4, s. 399-409Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
- 2007
-
Long-term biokinetics and radiation exposure of patients undergoing 14C-glycocholic acid and 14C-xylose breath tests.
Mikael Gunnarsson, Sigrid Leide Svegborn, Kristina Stenström, Göran Skog, Lars-Erik Nilsson, Ola Thorsson, Ragnar Hellborg & Sören Mattsson, 2007, I: Cancer Biotherapy & Radiopharmaceuticals. 22, 6, s. 762-771Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
-
Mouse S-factors based on monte carlo simulations in the anatomical realistic Moby phantom for internal dosimetry
Erik Larsson, Sven-Erik Strand, Michael Ljungberg & Bo-Anders Jönsson, 2007, I: Cancer Biotherapy & Radiopharmaceuticals. 22, 3, s. 438-442Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
Optimization of energy-window settings for scatter correction in quantitative In-111 imaging: Comparison of measurements and Monte Carlo simulations
Maria Holstensson, Cecilia Hindorf, Michael Ljungberg, Mike Partridge & Glenn D. Flux, 2007, I: Cancer Biotherapy & Radiopharmaceuticals. 22, 1, s. 136-142Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
-
Single-cell dosimetry for radioimmunotherapy of B-cell lymphoma patients with special reference to leukemic spread
Cecilia Hindorf, Dimitris Emfietzoglou, Ola Lindén, Christos Bousis, Andreas Fotopoulos, Kostas Kostarelos & Glenn D. Flux, 2007, I: Cancer Biotherapy & Radiopharmaceuticals. 22, 3, s. 357-366Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
- 2006
-
(99m)Tc-DTPA Uptake and Electrical Impedance Measurements in Verification of In Vivo Electropermeabilization Efficiency in Rat Muscle.
Gustav Grafström, Per Engström, Leif Salford & Bertil R Persson, 2006, I: Cancer Biotherapy & Radiopharmaceuticals. 21, 6, s. 623-635Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
-
Comparative renal, hepatic, and bone marrow toxicity of Cisplatin and radioactive Cisplatin ((191)pt) in wistar rats.
Kristina Norrgren, Maria Sjölin, Sven Bjorkman, Johan Areberg, Anders Johnsson, Leif Johansson & Sören Mattsson, 2006, I: Cancer Biotherapy & Radiopharmaceuticals. 21, 5, s. 528-534Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
- 2005
-
A novel platform for radioimmunotherapy: extracorporeal depletion of biotinylated and (90)y-labeled rituximab in patients with refractory B-cell lymphoma.
Ola Lindén, Jan Kurkus, Michael Garkavij, Eva Cavallin-Ståhl, Michael Ljungberg, Rune Nilsson, Tomas G Ohlsson, Bengt Sandberg, Sven-Erik Strand & Jan Tennvall, 2005, I: Cancer Biotherapy & Radiopharmaceuticals. 20, 4, s. 457-466Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
-
Dosimetry Calculations on a Tissue Level by Using the MCNP4c2 Monte Carlo Code.
Erik Larsson, Bo-Anders Jönsson, Lena M Jönsson, Michael Ljungberg & Sven-Erik Strand, 2005, I: Cancer Biotherapy & Radiopharmaceuticals. 20, 1, s. 85-91Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
-
Internal microdosimetry for single cells in radioimmunotherapy of B-cell lymphoma.
Cecilia Hindorf, Dimitris Emfietzoglou, Ola Lindén, Kostas Kostarelos & Sven-Erik Strand, 2005, I: Cancer Biotherapy & Radiopharmaceuticals. 20, 2, s. 224-230Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
-
Population biokinetic modeling of thyroid uptake and retention of radioiodine.
Johan Areberg, H Jönsson & Sören Mattsson, 2005, I: Cancer Biotherapy & Radiopharmaceuticals. 20, 1, s. 1-10Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
-
The LundADose Method for Planar Image Activity Quantification and Absorbed-Dose Assessment in Radionuclide Therapy.
Katarina Sjögreen Gleisner, Michael Ljungberg, Karin Wingårdh, David Minarik & Sven-Erik Strand, 2005, I: Cancer Biotherapy & Radiopharmaceuticals. 20, 1, s. 92-97Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
- 2004
-
Absorbed dose distribution in glioma tumors in rat brain after therapeutic intratumoral injection of 201Tl-chloride.
Kaj Ljunggren, Xiaowei Liu, Kjell Erlandsson, Michael Ljungberg, Leif Salford & Sven-Erik Strand, 2004, I: Cancer Biotherapy & Radiopharmaceuticals. 19, 5, s. 562-569Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
-
Blood pharmacokinetics of various mabs labeled with a new tri-chelating reagent for simultaneous conjugation with DOTA and biotin prior to radiolabeling
Zhongmin Wang, Linda Mårtensson, Rune Nilsson, Pär-Ola Bendahl, L Lindgren, Tomas G Ohlsson, H O Sjögren, Sven-Erik Strand & Jan Tennvall, 2004, I: Cancer Biotherapy and Radiopharmaceuticals. 19, 4, s. 540-541Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract
- 2003
-
3D absorbed dose calculations based on SPECT: Evaluation for 111-In/90-Y therapy using Monte Carlo simulations.
Michael Ljungberg, E Frey, Katarina Sjögreen Gleisner, XW Liu, Y Dewaraja & Sven-Erik Strand, 2003, I: Cancer Biotherapy & Radiopharmaceuticals. 18, 1, s. 99-107Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
-
Accuracy of the quantification of organ activity from planar gamma camera images
Kristina Norrgren, SL Svegborn, Johan Areberg & Sören Mattsson, 2003, I: Cancer Biotherapy & Radiopharmaceuticals. 18, 1, s. 125-131Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
-
Biokinetics of iodide in man: Refinement of current ICRP dosimetry models
L Johansson, Sigrid Leide Svegborn, Sören Mattsson & Bertil Nosslin, 2003, I: Cancer Biotherapy & Radiopharmaceuticals. 18, 3, s. 445-450Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
-
Biotinylation, pharmacokinetics, and extracorporeal adsorption of humanized MAb 111In-MN14 using an avidin-affinity column in rats.
Zhongmin Wang, Michael Garkavij, Tomas G Ohlsson, Sven-Erik Strand, Hans Olov Sjögren & Jan Tennvall, 2003, I: Cancer Biotherapy & Radiopharmaceuticals. 18, 3, s. 365-375Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
-
Calibration of a radioactive ink-based stack phantom and its applications in nuclear medicine.
H El-Ali, Michael Ljungberg, Sven-Erik Strand, John Palmer, Lars Malmgren & J Nilsson, 2003, I: Cancer Biotherapy & Radiopharmaceuticals. 18, 2, s. 201-207Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
-
Crypt cell dosimetry for 99Tcm-sestamibi in a new small intestinal dosimetry model.
Lena M Jönsson, Xiaowei Liu, Bo-Anders Jönsson, Michael Ljungberg & Sven-Erik Strand, 2003, I: Cancer Biotherapy & Radiopharmaceuticals. 18, 2, s. 217-223Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
-
Internal radionuclide dosimetry: diagnostic and therapeutic nuclear medicine, occupational and environmental exposures. Differences and similarities.
Sören Mattsson, Lars Jacobsson & Lennart Johansson, 2003, I: Cancer Biotherapy & Radiopharmaceuticals. 18, 3, s. 421-424Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
-
Single uptake measurement for absorbed dose planning for radioiodine treatment of hyperthyroidism.
Helene Jönsson & Sören Mattsson, 2003, I: Cancer Biotherapy & Radiopharmaceuticals. 18, 3, s. 473-479Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift